Latest RNA reports update at 2024-05-09: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Avidity Biosciences
  4. Financial Statements
Avidity Biosciences logo
Avidity Biosciences RNA
$ 27.1 3.99%
mail-toReport an Error

Avidity Biosciences Financial Statements 2011-2024 | RNA

Annual Financial Statements Avidity Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 1.1 B 1.25 B 703 M 523 M - - - - - - - - -

Shares

 73 M 52.2 M 41.4 M 21.7 M - - - - - - - - -

Historical Prices

 15.1 24 17 24.1 - - - - - - - - -

Net Income

 -212 M -174 M -118 M -44.4 M -24.7 M -11.2 M - - - - - - -

Revenue

 9.56 M 9.22 M 9.33 M 6.79 M 2.32 M 379 K - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - -

Operating Income

 -236 M -179 M -118 M -44.3 M -17.3 M -10.5 M - - - - - - -

Interest Expense

 -594 K -57 K -62 K 209 K 7.39 M 718 K - - - - - - -

EBITDA

 -233 M -178 M -117 M -43.9 M -17 M -10.1 M - - - - - - -

Operating Expenses

 245 M 188 M 127 M 51.1 M 19.7 M 10.9 M - - - - - - -

General and Administrative Expenses

 54.2 M 37.7 M 26.2 M 13.5 M 5.11 M 2.44 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Avidity Biosciences

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 87.2 M 79.3 M 74.1 M 71.4 M 70.4 M 69.8 M 53.1 M 49.9 M 48.2 M 47.8 M 43.3 M 37.6 M 37.5 M 37.6 M 37.4 M 8.59 M 2.84 M 2.99 M 2.74 M 2.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

 -68.9 M - -52.4 M -47 M -52.4 M - -43.6 M -45.7 M -34.2 M - -29.3 M -26.4 M -23.8 M -16.3 M -11.4 M -10.6 M -6.08 M -10.4 M -6.67 M -5.12 M -2.55 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

 3.54 M - 2.82 M 2.32 M 2.23 M - 2.48 M 2.18 M 1.8 M - 2.16 M 2.61 M 2.7 M 2.14 M 1.75 M 1.54 M 1.36 M 1.44 M 650 K 224 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

 -77.2 M - -58.6 M -52.6 M -57.6 M - -44.9 M -46.3 M -34.5 M - -29.3 M -26.4 M -23.9 M - -11.5 M -10.4 M -6.15 M - -5.21 M -3.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

 -101 K - -13 K -162 K -314 K - -12 K -2 K -25 K - -11 K -2 K - - - 131 K 78 K - 1.46 M 1.22 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

 -76.5 M - -58 M -52.1 M -57.2 M - -44.5 M -46 M -34.1 M - -29.1 M -26.3 M -23.7 M - -11.4 M -10.3 M -6.07 M - -4.94 M -3.72 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

 80.7 M - 61.4 M 55 M 59.8 M - 47.4 M 48.5 M 36.3 M - 31.4 M 29 M 26.6 M 18.4 M 13.2 M 11.9 M 7.51 M 7.49 M 5.86 M 4.13 M 2.17 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

 13.9 M - 13.7 M 12.3 M 12.1 M - 10.1 M 8.69 M 8.57 M - 6.61 M 6.27 M 5.88 M - 3.76 M 2.92 M 1.96 M - 757 K 1.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency